Format

Send to:

Choose Destination
See comment in PubMed Commons below
Thorax. 2015 Jun;70(6):595-7. doi: 10.1136/thoraxjnl-2014-206304. Epub 2015 Jan 23.

Developmental determinants in non-communicable chronic diseases and ageing.

Author information

  • 1University Hospital, Montpellier, France Inserm U 1168, Paris, France Contre les Maladies Chroniques pour un Vieillissement Actif en Languedoc Roussillon, Site de Référence de l'EIP on AHA, Montpellier, France MeDALL, Mechanisms of the Development of Allergy, FP7, Amsterdam, Groningen, the Netherlands.
  • 2MeDALL, Mechanisms of the Development of Allergy, FP7, Amsterdam, Groningen, the Netherlands Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain Universitat Pompeu Fabra (UPF), Barcelona, Spain CIBER Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain.
  • 3Deputy Head of Unit for Medical Research and the Challenge of Ageing, DG Research & Innovation, European Commission, Brussels, Belgium.
  • 4National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA.
  • 5European Commission, Directorate General for Health and Consumers, Brussels, Belgium.
  • 6Contre les Maladies Chroniques pour un Vieillissement Actif en Languedoc Roussillon, Site de Référence de l'EIP on AHA, Montpellier, France University Montpellier 1, France.
  • 7Contre les Maladies Chroniques pour un Vieillissement Actif en Languedoc Roussillon, Site de Référence de l'EIP on AHA, Montpellier, France Région Languedoc Roussillon, France.
  • 8Contre les Maladies Chroniques pour un Vieillissement Actif en Languedoc Roussillon, Site de Référence de l'EIP on AHA, Montpellier, France Montpellier Medical School, France.
  • 9Contre les Maladies Chroniques pour un Vieillissement Actif en Languedoc Roussillon, Site de Référence de l'EIP on AHA, Montpellier, France Department of Physiology, Montpellier University Hospital, France University Montpellier 1, France.
  • 10Contre les Maladies Chroniques pour un Vieillissement Actif en Languedoc Roussillon, Site de Référence de l'EIP on AHA, Montpellier, France Nimes University Hospital, France.
  • 11Contre les Maladies Chroniques pour un Vieillissement Actif en Languedoc Roussillon, Site de Référence de l'EIP on AHA, Montpellier, France Montpellier University Hospital, France.
  • 12MeDALL, Mechanisms of the Development of Allergy, FP7, Amsterdam, Groningen, the Netherlands Swiss Institute of Allergy and Asthma Research (SIAF), Davos and University of Zurich, Switzerland.
  • 13David Hide Asthma and Allergy Research Centre, Isle of Wight, UK.
  • 14Contre les Maladies Chroniques pour un Vieillissement Actif en Languedoc Roussillon, Site de Référence de l'EIP on AHA, Montpellier, France.
  • 15Contre les Maladies Chroniques pour un Vieillissement Actif en Languedoc Roussillon, Site de Référence de l'EIP on AHA, Montpellier, France Inserm, Research Unit U1061, University Montpellier I, Montpellier, France.
  • 16Department of Paediatric Respiratory Medicine, Royal Brompton Hospital and National Heart and Lung Institute, Imperial College, London, UK.
  • 17Contre les Maladies Chroniques pour un Vieillissement Actif en Languedoc Roussillon, Site de Référence de l'EIP on AHA, Montpellier, France Institute of Human Genetics, CNRS, Montpellier, France.
  • 18Equipe 10 UMR Inserm-Université Paris-Sud (Centre de recherche en Epidémiologie et Santé des Populations, CESP), Villejuif, France.
  • 19Nutrition, Hormones and Women's Health Team, INSERM UMR-S 1018, Paris-South University, Villejuif, France.
  • 20Obesity Prevention Program, Department of Population Medicine, Harvard Medical School/Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA Department of Nutrition, Harvard School of Public Health, Boston, Massachusetts, USA.
  • 21Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, and Harvard School of Public Health, UK.
  • 22Population-Based Epidemiological Cohorts, INSERM-UVSQ UMS 011, Villejuif, France.
  • 23Human Development & Health, Faculty of Medicine, University of Southampton, Southampton, UK.
  • 24Institute of Clinical Physiology, National Research Council (CNR), Pisa, Italy.
  • 25Contre les Maladies Chroniques pour un Vieillissement Actif en Languedoc Roussillon, Site de Référence de l'EIP on AHA, Montpellier, France Horiba, Montpellier, France.
  • 26Contre les Maladies Chroniques pour un Vieillissement Actif en Languedoc Roussillon, Site de Référence de l'EIP on AHA, Montpellier, France Department of Geriatrics, University Hospital, Montpellier, France.
  • 27MeDALL, Mechanisms of the Development of Allergy, FP7, Amsterdam, Groningen, the Netherlands CESP-Team of Respiratory and Environmental Epidemiology INSERM UMR-S1018, University Paris-Sud, Villejuif, France.
  • 28MeDALL, Mechanisms of the Development of Allergy, FP7, Amsterdam, Groningen, the Netherlands Institute of Social Medicine, Epidemiology and Health Economics, Charité-Universitätsmedizin, Berlin, Germany Institute for Clinical Epidemiology and Biometry, Julius Maximilian University of Wuerzburg, Germany.
  • 29MeDALL, Mechanisms of the Development of Allergy, FP7, Amsterdam, Groningen, the Netherlands Department of Pediatric Pulmonology and Pediatric Allergology, University of Groningen, University Medical Center Groningen, Beatrix Children's Hospital, Groningen Research Institute for Asthma and COPD, Groningen, The Netherlands.
  • 30Comprehensive Pneumology Center, Ludwig Maximilians University and Helmholtz Zentrum Muenchen, Member of the German Research Center for Lung Research, Großhadern, Germany.
  • 31MRC Unit for Lifelong Health and Ageing at UCL, London, UK.
  • 32Contre les Maladies Chroniques pour un Vieillissement Actif en Languedoc Roussillon, Site de Référence de l'EIP on AHA, Montpellier, France Institut de Médecine Régénératrice et de Biothérapie (I.M.R.B.), University Hospital, INSERM U1040, Montpellier, France.
  • 33MeDALL, Mechanisms of the Development of Allergy, FP7, Amsterdam, Groningen, the Netherlands Department of Paediatrics, University of Oslo and Oslo University Hospital, Oslo, Norway.
  • 34MeDALL, Mechanisms of the Development of Allergy, FP7, Amsterdam, Groningen, the Netherlands Biomax Informatics AG, Planegg, Germany.
  • 35Institute of Human Genetics, CNRS, Montpellier, France.
  • 36MeDALL, Mechanisms of the Development of Allergy, FP7, Amsterdam, Groningen, the Netherlands Institute of Environmental Medicine, Karolinska Institutet and Sachs' Children's Hospital, Stockholm, Sweden.
  • 37Aix-Marseille University (AMU), Research Unit 912 AMU/INSERM/IRD Social and Economic Sciences Applied to Health (SESSTIM), France.
  • 38MeDALL, Mechanisms of the Development of Allergy, FP7, Amsterdam, Groningen, the Netherlands Department of Public health and biostatistics, Descartes University, Paris, France Municipal Department of social action, childhood, and health, Paris, France.
  • 39Contre les Maladies Chroniques pour un Vieillissement Actif en Languedoc Roussillon, Site de Référence de l'EIP on AHA, Montpellier, France SATT AxLR, Montpellier, France.
  • 40MeDALL, Mechanisms of the Development of Allergy, FP7, Amsterdam, Groningen, the Netherlands Department of Pulmonology, University Medical Center Groningen, University of Groningen, GRIAC Research Institute, Groningen, The Netherlands.
  • 41Contre les Maladies Chroniques pour un Vieillissement Actif en Languedoc Roussillon, Site de Référence de l'EIP on AHA, Montpellier, France Inserm U1061 Neuropsychiatry, Montpellier and Faculty of Medicine, Imperial College London, London, UK.
  • 42Contre les Maladies Chroniques pour un Vieillissement Actif en Languedoc Roussillon, Site de Référence de l'EIP on AHA, Montpellier, France Inserm Research Unit 988, Paris, France Inserm Research Unit 710, Montpellier, France Ecole Pratique des Hautes Etudes (EPHE), Paris, France.
  • 43Department of Prevention of Environmental Hazards and Allergology, Medical University of Warsaw, Warsaw, Poland.
  • 44MeDALL, Mechanisms of the Development of Allergy, FP7, Amsterdam, Groningen, the Netherlands Team of Environmental Epidemiology applied to Reproduction and Respiratory Health, University Grenoble Alpes, IAB, Grenoble, France Team of Environmental Epidemiology applied to Reproduction and Respiratory Health, INSERM, IAB, Grenoble, France Team of Environmental Epidemiology applied to Reproduction and Respiratory Health, CHU de Grenoble, IAB, Grenoble, France.
  • 45Section of Molecular Epidemiology, Leiden University Medical Center, Leiden, the Netherlands Consortium for Healthy Aging, Leiden University Medical Center, Leiden, the Netherlands.
  • 46MeDALL, Mechanisms of the Development of Allergy, FP7, Amsterdam, Groningen, the Netherlands Julius Center of Health Sciences and Primary Care, University Medical Center Utrecht, University of Utrecht, Utrecht, the Netherlands.
  • 47MeDALL, Mechanisms of the Development of Allergy, FP7, Amsterdam, Groningen, the Netherlands Division of Immunopathology, Department of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.
  • 48University Hospital and INSERM U 1058, Montpellier, France.
  • 49Contre les Maladies Chroniques pour un Vieillissement Actif en Languedoc Roussillon, Site de Référence de l'EIP on AHA, Montpellier, France EPHE, Section des Sciences de la Vie et de la Terre, Paris, France UMR S 710, University Montpellier 2, Montpellier, Paris, France Institut Transdisciplinaire d'Etudes du Vieillissement, Montpellier, France.
  • 50Centre for Research in Environmental Epidemiology (CREAL), Barcelona, Spain Universitat Pompeu Fabra (UPF), Barcelona, Spain CIBER Epidemiología y Salud Pública (CIBERESP), Barcelona, Spain.
  • 51Cyprus International Institute for Environmental & Public Health in Association with Harvard School of Public Health, Cyprus University of Technology, Limassol, Cyprus.
  • 52Director of Population-Based Epidemiological Cohorts, INSERM-UVSQ UMS 011, Villejuif, France.

Abstract

Prenatal and peri-natal events play a fundamental role in health, development of diseases and ageing (Developmental Origins of Health and Disease (DOHaD)). Research on the determinants of active and healthy ageing is a priority to: (i) inform strategies for reducing societal and individual costs of an ageing population and (ii) develop effective novel prevention strategies. It is important to compare the trajectories of respiratory diseases with those of other chronic diseases.

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

KEYWORDS:

Asthma; COPD ÀÜ Mechanisms; Paediatric asthma

PMID:
25616486
[PubMed - indexed for MEDLINE]
PMCID:
PMC4422754
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire Icon for PubMed Central
    Loading ...
    Write to the Help Desk